Segment 5: Proper Use of Tests

Bryan Loy, MD, MBA, discusses how payers can measure diagnostic test use and results, and Daniel Hayes, MD, weighs in with how CancerLinQ from the American Society of Clinical Oncology can help.

Although diagnostic testing is not currently regulated by the FDA, payers will commonly take a look at what’s going on in other areas where there is FDA approval and determine what sorts of signals can come from claims data and other information, said Bryan Loy, MD, MBA.

“Having some processes in place to not only measure signals, but also how folks are using the test and the results has become very important,” he said.

Daniel Hayes, MD, added that he hopes CancerLinQ from the American Society of Clinical Oncology will ensure that physicians are using tests properly, which is a matter of education and training.